Development and Validation of a Machine Learning Approach for Automated Severity Assessment of COVID-19 Based on Clinical and Imaging Data: Retrospective Study
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background: COVID-19 has overwhelmed health systems worldwide. It is important to identify severe cases as early as possible, such that resources can be mobilized and treatment can be escalated. Objective: This study aims to develop a machine learning approach for automated severity assessment of COVID-19 based on clinical and imaging data. Methods: Clinical data—including demographics, signs, symptoms, comorbidities, and blood test results—and chest computed tomography scans of 346 patients from 2 hospitals in the Hubei Province, China, were used to develop machine learning models for automated severity assessment in diagnosed COVID-19 cases. We compared the predictive power of the clinical and imaging data from multiple machine learning models and further explored the use of four oversampling methods to address the imbalanced classification issue. Features with the highest predictive power were identified using the Shapley Additive Explanations framework. Results: Imaging features had the strongest impact on the model output, while a combination of clinical and imaging features yielded the best performance overall. The identified predictive features were consistent with those reported previously. Although oversampling yielded mixed results, it achieved the best model performance in our study. Logistic regression models differentiating between mild and severe cases achieved the best performance for clinical features (area under the curve [AUC] 0.848; sensitivity 0.455; specificity 0.906), imaging features (AUC 0.926; sensitivity 0.818; specificity 0.901), and a combination of clinical and imaging features (AUC 0.950; sensitivity 0.764; specificity 0.919). The synthetic minority oversampling method further improved the performance of the model using combined features (AUC 0.960; sensitivity 0.845; specificity 0.929). Conclusions: Clinical and imaging features can be used for automated severity assessment of COVID-19 and can potentially help triage patients with COVID-19 and prioritize care delivery to those at a higher risk of severe disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A logical calculus of the ideas immanent in nervous activity
McCulloch, W. S., & Pitts, W. (1943) · The Bulletin of Mathematical Biophysics · doi:10.1007/bf02478259 · Cited by 18,566
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., Fan, Y., & Zheng, C. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30086-4 · Cited by 3,664
Wynants, L., Van Calster, B., Bonten, M. M., Collins, G. S., Debray, T. P., De Vos, M., Haller, M. C., Heinze, G., Moons, K. G., Riley, R. D., et al. (2020) · doi:10.1101/2020.03.24.20041020 · Cited by 3,070
PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies
Wolff, R. F., Moons, K. G. M., Riley, R. D., Whiting, P. F., Westwood, M., Collins, G. S., Reitsma, J. B., Kleijnen, J., Mallett, S., & for the PROBAST Group† (2019) · Annals of Internal Medicine · doi:10.7326/m18-1376 · Cited by 2,984
Li, L., Qin, L., Xu, Z., Yin, Y., Wang, X., Kong, B., Bai, J., Lu, Y., Fang, Z., Song, Q., et al. (2020) · Radiology · doi:10.1148/radiol.2020200905 · Cited by 1,927
Shi, F., Wang, J., Shi, J., Wu, Z., Wang, Q., Tang, Z., He, K., Shi, Y., & Shen, D. (2021) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2020.2987975 · Cited by 1,404 · cited 1×
“Recent reviews provide more details regarding these architectures [1,28-32].”
BackgroundA Deep Learning System to Screen Novel Coronavirus Disease 2019 Pneumonia
Xu, X., Jiang, X., Ma, C., Du, P., Li, X., Lv, S., Yu, L., Ni, Q., Chen, Y., Su, J., et al. (2020) · Engineering · doi:10.1016/j.eng.2020.04.010 · Cited by 1,209
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
Mei, X., Lee, H.-C., Diao, K.-Y., Huang, M., Lin, B., Liu, C., Xie, Z., Ma, Y., Robson, P. M., Chung, M., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0931-3 · Cited by 1,084
Lalmuanawma, S., Hussain, J., & Chhakchhuak, L. (2020) · Chaos, Solitons & Fractals · doi:10.1016/j.chaos.2020.110059 · Cited by 845
Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment
Jamshidi, M., Lalbakhsh, A., Talla, J., Peroutka, Z., Hadjilooei, F., Lalbakhsh, P., Jamshidi, M., Spada, L. L., Mirmozafari, M., Dehghani, M., et al. (2020) · IEEE Access · doi:10.1109/access.2020.3001973 · Cited by 551
Cited by
Wynants, L., Van Calster, B., Bonten, M. M., Collins, G. S., Debray, T. P., De Vos, M., Haller, M. C., Heinze, G., Moons, K. G., Riley, R. D., et al. (2020) · doi:10.1101/2020.03.24.20041020 · Cited by 3,070
Ağbulut, Ü. (2022) · Sustainable Production and Consumption · doi:10.1016/j.spc.2021.10.001 · Cited by 277
Ennab, M., & Mcheick, H. (2024) · Frontiers in Robotics and AI · doi:10.3389/frobt.2024.1444763 · Cited by 238
Abdulaal, A., Patel, A., Al-Hindawi, A., Charani, E., Alqahtani, S. A., Davies, G. W., Mughal, N., & Moore, L. S. P. (2021) · JMIR Formative Research · doi:10.2196/27992 · Cited by 13
“While numerous recent studies have been using machine learning processes for aspects of COVID-19 clinical care in various settings [26-30], few use co-design, as we have in this study, to optimize the utility of the app among clinicians.”
Method
Metadata
- Authors
- Quiroz, J. C., Feng, Y.-Z., Cheng, Z.-Y., Rezazadegan, D., Chen, P.-K., Lin, Q.-T., Qian, L., Liu, X.-F., Berkovsky, S., Coiera, E., Song, L., Qiu, X., Liu, S., & Cai, X.-R.
- Venue
- JMIR Medical Informatics
- Publisher
- JMIR Publications Inc.
- Published
- 2021-02-11
- Volume
- 9
- Issue
- 2
- Pages
- e24572
- ISSN
- 2291-9694 (ISSN-L)
- OpenAlex
- W3129080628
- Cited by
- 52
- References
- 11
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.